On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
WednesdayMar 15, 2017 11:30 am

Catasys, Inc. (CATS) Starts Presentation at 29th Annual ROTH Conference

Catasys (OTC: CATS) provides big data based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak solution. The company's OnTrak solution is designed to improve member health and lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. The solution utilizes proprietary analytics and proprietary enrollment, engagement and behavioral modification capabilities to assist members who otherwise do not seek care through a patient-centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient treatment solution. For more information, visit the…

Continue Reading

WednesdayMar 15, 2017 11:10 am

BioVie, Inc. (BIVI) Develops New Approaches to Devastating Liver Diseases

It’s estimated that over one million Americans and millions more worldwide suffer from liver cirrhosis. Globally, it accounted for over 1.2 million deaths in 2013, and it's the 12th leading cause of death by disease in the United States, where 27,000 Americans die each year from the disease. Worldwide, 57 percent of cirrhosis is attributable to either hepatitis C or hepatitis B. Long-term alcohol abuse accounts for about 20 percent of cirrhosis-related deaths globally, while, in the United States, 40 percent of cirrhosis-related deaths are caused by alcohol abuse. Each of these disease drivers triggers the replacement of normal liver…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) Starts Presentation at 29th Annual Roth Conference

Perma-Fix Environmental (NASDAQ: PESI) operates as an environmental and technology know-how company in the United States. Its Treatment segment offers nuclear, low-level radioactive, mixed, hazardous, and non-hazardous waste treatment, processing, and disposal services through licensed and permitted treatment and storage facilities. This segment also engages in the research and development activities to identify, develop, and implement waste processing techniques for problematic waste streams. The company’s Services segment provides on-site waste management services to commercial and government customers; and owns an equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources health physics and industrial hygiene, as well as customized…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Tandy Leather Factory (NASDAQ: TLF) Starts Presentation at 29th Annual Roth Conference

Tandy Leather Factory (NASDAQ: TLF) operates as a retailer and wholesale distributor of a range of leather and related products. The company offers leather, leatherworking tools, buckles and adornments for belts, leather dyes and finishes, and saddle and tack hardware. It also manufactures leather lacing and do-it-yourself kits. It serves individuals, wholesale distributors, tack and saddle shops, western stores, craft stores and craft store chains, other large volume purchasers, manufacturers, retailers, youth groups, summer camps, quine-related shops, cobblers and dealers, as well as institutions, such as prisons and prisoners, schools, and hospitals. For more information, visit the company’s website at…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Synthetic Biologics Inc. (NYSE: SYN) Starts Presentation at 29th Annual Roth Conference

Synthetic Biologics (NYSE: SYN) is a late-stage clinical company that engages in developing therapeutics designed to preserve the microbiome to protect and restore the health of patients in the United States. Its lead product candidates in phase III development include SYN-010, which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase) that is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD),…

Continue Reading

WednesdayMar 15, 2017 11:00 am

ITM Power Plc (ITMPF) Starts Presentation at 29th Annual ROTH Conference

ITM Power (OTC: ITMPF) designs, manufactures, and sells hydrogen energy systems for energy storage and clean fuel production in the United Kingdom. It offers HGas for power-to-gas applications; HFuel, a self-contained module for refueling hydrogen-powered road vehicles and forklift trucks; and HPac, a proton-exchange membrane electrolyser. The company is also involved in the research and development of scientific and engineering projects; development and manufacture of prototype products; and sale of electrolysis equipment and hydrogen storage solutions. Additionally, the company operates three hydrogen refueling stations. For more information, visit the company’s website at www.itm-power.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Professional Diversity Net, Inc. (NASDAQ: IPDN) Starts Presentation at 29th Annual Roth Conference

Professional Diversity Net (NASDAQ: IPDN) operates online professional networking communities with career resources in the United States. It operates through three segments, Professional Diversity Network, National Association of Professional Women and Noble Voice Operations. The company serves various cultural groups such as Hispanic-Americans, African-Americans, Asian-Americans, the disabled, military professionals, LBGT communities, plus women’s groups, students and graduates. It offers single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising as well as e-newsletter marketing, research and outreach services. For more information, visit the company’s website at www.profusional.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

Continue Reading

WednesdayMar 15, 2017 10:44 am

GreeneStone Healthcare Corp. (GRST) Helping Tackle the Effects of Substance Abuse on Young Adults and Children in Florida

Addiction, a chronic brain disease that induces compulsive activity leading to many legal, social, and health consequences, is a problem that has swept over the world. Although this disease may start as a positive experience for the user, the outcome is normally devastating or even fatal. In the U.S., pharmaceutical opioids and heroin are two of the most problematic substances, causing thousands of deaths annually. However, it’s not just opioids and heroin causing problems. Millions of Americans are addicted to other drugs and alcohol. Florida, specifically, is known as a state of hard drinking. It is also known as a…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Mateon Therapeutics, Inc. (NASDAQ: MATN) Starts Presentation at 29th Annual Roth Conference

Mateon Therapeutics (NASDAQ: MATN) is a biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent, which has completed Phase II clinical trial for treating recurrent ovarian cancer; and in Phase II clinical trial for treating gastrointestinal neuroendocrine tumors. The company also develops OXi4503 that is in Phase I/II clinical trial stage for treating patients with relapsed or refractory acute myelogenous leukemia or myelodysplastic syndromes. For more information, visit the company’s website at www.mateon.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

WednesdayMar 15, 2017 10:30 am

KemPharm, Inc. (NASDAQ: KMPH) Starts Presentation at 29th Annual Roth Conference

KemPharm (NASDAQ: KMPH) is a clinical-stage specialty pharmaceutical company that discovers and develops new proprietary prodrugs in the United States. Its advanced product candidate is KP201/APAP, which consists of KP201 prodrug of hydrocodone formulated in combination with acetaminophen (APAP). The company is also developing KP201/APAP as an immediate release (IR) product candidate for the treatment of acute pain, as well as engages in designing KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain. For more…

Continue Reading

Contact us: 212.418.1217